CBULF yields 11428.57% · MRK yields 2.81%● Live data
📍 CBULF pulled ahead of the other in Year 1
Combined, CBULF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CBULF + MRK for your $10,000?
Gratomic Inc., a junior exploration company, engages in the acquisition and exploration of assets primarily in Canada and Namibia. It explores for base and rare metals, industrial minerals, and precious metals. The company holds a 100% interest in the Aukam graphite project located in the district of Bethanie, Karas Region of southern Namibia covers an area of approximately 137,473 hectares; and a 100% interest in the Buckingham graphite property that includes eight claim blocks covering an area of approximately 480 hectares located in the Quebec, Canada. It also holds a 100% interest in the Capim Grosso Property, which comprises an area of 426.03 hectares located in Capim Grosso, Brazil. The company was formerly known as CKR Carbon Corporation and changed its name to Gratomic Inc. in December 2017. Gratomic Inc. was incorporated in 2007 and is based in Toronto, Canada.
Full CBULF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.